May 2, 2023Anavex Life Sciences to Announce Fiscal 2023 Second Quarter Financial Resultson Tuesday May 9, 2023
Apr 25, 2023Anavex Life Sciences to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
Apr 10, 2023Anavex Life Sciences to Present at the 22nd Annual Needham Virtual Healthcare Conference 2023
Mar 30, 2023ANAVEX®2-73 (Blarcamesine) Shows Clinical Benefit in Long-Term 48Week Phase 2 Extension Study in PDD
Mar 9, 2023Anavex Life Sciences Appoints Former FDA Lead Neurology Statistician as VP Head of Biostatistics
Feb 2, 2023Anavex Life Sciences Announces Exceeding of Enrollment Target for ANAVEX®2-73 (blarcamesine)
Jan 31, 2023Anavex Life Sciences to Announce Fiscal 2023 First Quarter Financial Results on February 7, 2023